Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan 1;19(1):524-33.
doi: 10.1016/j.bmc.2010.10.065. Epub 2010 Nov 5.

Identification of 3-phenylaminoquinolinium and 3-phenylaminopyridinium salts as new agents against opportunistic fungal pathogens

Affiliations

Identification of 3-phenylaminoquinolinium and 3-phenylaminopyridinium salts as new agents against opportunistic fungal pathogens

Tryphon K Mazu et al. Bioorg Med Chem. .

Abstract

Previous studies on the indoloquinoline alkaloid, cryptolepine (2), revealed that it has antii-nfective properties among other activities. Using Structure-activity relationship (SAR) techniques, several ring-opened analogs of cryptolepine (3-phenylaminopyridinium and 3-phenylaminoquinolinium derivatives) were designed to improve the potency and lower the cytotoxicity shown by several of the precursor agents. Results indicate that these ring-opened analogs constitute new anti-infective agents with over a 100-fold potency and several fold lower cytotoxicity than cryptolepine from which they are derived.

PubMed Disclaimer

Figures

Scheme I
Scheme I
Reagents and conditions: (i) CH2Cl2, Cu(OAc)2, TEA, MS-Powder, RT, 12–24 hr; (ii) Pd(OAc)2, CF3COOH, 80 °C, 6 h; (iii) CH3I, Toluene 110 °C, 12–24 h, sealed tube.
Scheme II
Scheme II
(i) Aqueous KOH, 10 days. (ii) Paraffin oil, 300 °C, 3 h.; (iii) NaH, R1-I, DME, rt, 12 h; (iv) CH3I, Toluene, 110 °C, 12–24 h or CH3OTf, Toluene, rt, 24 h.
Scheme III
Scheme III
Reagents and conditions :( i) 1, 5-Dibromopentane, Li2CuCl4, THF, 0°C, 12 h, (ii) NaI, Acetone, Reflux, 12h.
Scheme IV
Scheme IV
Reagents and conditions: (i) NaH, Cyclohexylpentyl iodide, DME, RT, 12 h; (ii) CH3I, Toluene 110 °C, 12–24 h
Scheme V
Scheme V
Reagents and conditions: (i) (Y = B(OH)2), CH2Cl2, Cu(OAc)2, TEA, Molecular sieve, RT, 24 h, (Y = Br, I) Dioxane, Pd(OAc)2 , 80°C, 24 h; (ii) DME, 5-iodo-pentylcyclohexane, NaH, 0°C, RT, 12 h; (iii) CH3I, Toluene, 110°C, 12 h.

References

    1. www.cdc.gov.
    1. Karkowska-Kuleta J, Rapala-Kozik M, Kozik A. Acta Biochim Pol. 2009;56:211. - PubMed
    2. Richardson MD. J Antimicrob. Chemother. 2005;56 Suppl 1:i5. - PubMed
    3. Hong W, Wen H, Liao W. Chin. Med. J. (Engl) 2003;116:1421. - PubMed
    4. Clark TA, Hajjeh RA. Curr. Opin. Infect. Dis. 2002;15:569. - PubMed
    5. Maertens J, Vrebos M, Boogaerts M. Eur J Cancer Care. 2001;10:56. - PubMed
    1. www.unaids.org.
    2. www.avert.org.
    1. Chen J, Varma A, Diaz MR, Litvintseva AP, Wollenberg KK, Kwon-Chung K. J. Emerg Infect Dis. 2008;14:755. - PMC - PubMed
    1. Groll AH, Tragiannidis A. Semin. Hematol. 2009;46:212. - PubMed
    2. Groll AH, Walsh TJ. Clin Microbiol Infect. 2001;7 suppl 2:8. - PubMed
    3. Groll AH, Walsh TJ. Swiss Med. Wkly. 2002:132. - PubMed

Publication types

MeSH terms